The impact of repeated rounds of mass drug-administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea

PLoS Neglected Tropical Diseases

Volumn 2, Issue 12, 2008, Pages

  Weill, Gary J ^a   Kastens, Will ^b   Susapu, Melinda ^c   Laney, Sandra J ^d   Williams, Steven A ^d   King, Christopher L ^b   Kazura, James W ^b   Bockarie, Moses J ^b,c,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^d SMITH COLLEGE   (United States)

^e LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; ANTHELMINTIC AGENT; HELMINTH DNA; PARASITE ANTIGEN;

ADOLESCENT; ADULT; ANOPHELES; ARTICLE; BANCROFTIAN FILARIASIS; CHILD; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LARVA; MAJOR CLINICAL STUDY; MALE; MICROFILARIASIS; MONITORING; MOSQUITO; PAPUA NEW GUINEA; PATIENT COMPLIANCE; RURAL AREA; WORLD HEALTH ORGANIZATION; AGING; ANIMAL; BLOOD; DRUG COMBINATION; FILARIASIS; GENETICS; IMMUNOLOGY; LYMPHATIC FILARIASIS; PARASITOLOGY; PREVALENCE;

ADULT; AGING; ALBENDAZOLE; ANIMALS; ANOPHELES; ANTHELMINTICS; ANTIGENS, HELMINTH; CHILD; CULICIDAE; DIETHYLCARBAMAZINE; DNA, HELMINTH; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; FILARIASIS; HUMANS; PAPUA NEW GUINEA; PATIENT COMPLIANCE; PREVALENCE;

EID: 65549139301     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000344     Document Type: Article

References (38)

1. Ottesen EA, Duke BO, Karam M, Behbehani K (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Org 75: 491-503.
2. Ottesen EA (2006) Lymphatic filariasis: Treatment, control, and elimination. Adv Parasitol 61: 395-441.
3. World Health Organization (2008) Global programme to eliminate lymphatic filariasis: Progress report on mass drug administration in 2007. Wkly Epidemiol Rec 83: 333-341.
4. El Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, et al. (2007) The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 77: 1069-1073.
5. Ramzy RMR, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, et al. (2006) Effect of yearly mass drug administration with diethycarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 367: 992-999.
6. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, et al. (2002) Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 347: 1841-1848.
7. Michael E, Bundy DAP (1997) Global mapping of lymphatic filariasis. Parasitology Today 13: 472-476.
8. Bryan JH (1986) Vectors of Wuchereria bancrofti in the Sepik Provinces of Papua New Guinea. Trans R Soc Trop Med Hyg 80: 123-131.
9. Ichimori K, Crump A (2005) Pacific collaboration to eliminate lymphatic filariasis. Trends Parasitol 21: 441-444.
10. Webber RH (1975) Vector control of filariasis in the Solomon Islands. Southeast Asian J Trop Med Public Health 6: 430-434.
11. Bockarie MJ, Kazura JW (2003) Lymphatic filariasis in Papua New Guinea: prospects for elimination. Med Microbiol Immunol (Berl) 192: 9-14.
12. Bockarie MJ, Tavul L, Ibam I, Kastens W, Hazlett F, et al. (2007) Efficacy of single-dose diethylcarbamazine compared with diethycarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg 76: 62-66.
13. Selve BP, Bwadua S, Misa M, James K, Usurup JP, et al. (2000) Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole. P N G Med J 43: 183-187.
14. World Health Organization (2000) Preparing and implementing a national plan to eliminate lymphatic filariasis in countries where onchocerciasis is not coendemic. Geneva: WHO.
15. Charlwood JD, Bryan JH (1987) A mark-recapture experiment with the filariasis vector Anopheles punctulatus in Papua New Guinea. Ann Trop Med Parasitol 81: 429-436.
16. Desowitz RS, Hitchcock JC (1974) Hyperendemic bancroftian filariasis in the Kingdom of Tonga: the application of the membrane filter concentration technique to an age-stratified blood survey. Am J Trop Med Hyg 23: 877-879.
17. Remme J, Ba O, Dadzie K, Karam M (1986) A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bulletin of the World Health Organization 64: 667-681.
18. Chandrasena TG, Premaratna R, Abeyewickrema W, de Silva NR (2002) Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka. Trans R Soc Trop Med Hyg 96: 60-63.
19. Weil GJ, Lammie PJ, Weiss N (1997) The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 13: 401-404.
20. Ramzy RM, Helmy H, Faris R, Gad AM, Chandrashekar R, et al. (1995) Evaluation of a recombinant antigen-based antibody assay for diagnosis of bancroftian filariasis in Egypt. Ann Trop Med Parasitol 89: 443-446.
21. Chandrashekar R, Curtis KC, Ramzy RM, Liftis F, Li B-W, et al. (1994) Molecular cloning of Brugia malayi antigens for diagnosis of lymphatic filariasis. Mol Biochem Parasitol 64: 261-274.
22. Lammie P, Weil G, Rahmah N, Kaliraj P, Steel C, et al. (2004) Recombinant antigen based assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial. Filaria Journal 3: 9.
23. Plichart C, Laney SJ, Sechan Y, Davies N, Legrand AM (2007) Correction: PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia. Filaria J 6: 5.
24. Plichart C, Sechan Y, Davies N, Legrand AM (2006) PCR and dissection as tools to monitor filarial infection of Aedes polynesiensis mosquitoes in French Polynesia. Filaria J 5: 2.
25. Williams S, Laney S, Bierwert L, Saunders L, Boakye D, et al. (2002) Development and standardization of a rapid PCR-based method for the detection of Wuchereria bancrofti in mosquitoes for xenomonitoring the human prevalence of bancroftian filariasis. Ann Trop Med Parasitol 96: S41-46.
26. Laney SJ, Buttaro CJ, Visconti S, Pilotte N, Ramzy RMR, et al. (2008) A reverse transcriptase-PCR assay for detecting filarial infective larvae in mosquitoes. PLoS Negl Trop Dis 2: e251. doi:10.1371/ journal.pntd.0000251.
27. Katholi CR, Toé L, Merriweather A, Unnasch TR (1995) Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis 172: 1414-1417.
28. Njenga SM, Wamae CN, Njomo DW, Mwandawiro CS, Molyneux DH (2008) Impact of two rounds of mass treatment with diethycarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatography test in Malindi, Kenya. Trans R Soc Trop Med Hyg: in press.
29. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, et al. (1999) A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. Am J Trop Med Hyg 61: 53-58.
30. Weil GJ, Ramzy RMR (2007) Diagnostic tools for filariasis elimination programmes. Trends Parasitol 23: 78-82.
31. Simonsen PE, Magesa SM, Meyrowitsch DW, Malacela-Lazaro MN, Rwegoshora RT, et al. (2005) The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenemia. Trans R Soc Trop Med Hyg 99: 541-547.
32. Tisch DJ, Bockarie MJ, Dimber Z, Kiniboro B, Tarongka N, et al. (2008) Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: Changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. Am J Trop Med Hyg 78: 289-293.
33. Fischer P, Erickson SM, Fischer K, Fuchs JF, Rao RU, et al. (2007) Persistence of Brugia malayi DNA in vector and non-vector mosquitoes: implications for xenomonitoring and transmission monitoring of lymphatic filariasis. Am J Trop Med Hyg 76: 502-507.
34. McGreevy PB, Bryan JH, Oothuman P, Kolstrup N (1978) The lethal effects of the cibarial and pharyngeal armatures of mosquitoes on microfilariae. Trans R Soc Trop Med Hyg 72: 361-368.
35. Pichon G (2002) Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Annals of Tropical Medicine and Parasitology 96: S143-S152.
36. El Setouhy M, Ramzy R, Ahmed E, Kandil A, Hussain O, et al. (2004) A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg 70: 191-196.
37. Helmy H, Weil GJ, Ellethy AS, Ahmed ES, El Setouhy M, et al. (2006) Bancroftian filariasis: Effect of repeated treatment with diethycarbamazine and albendazole on microfilaremia, antigenemia, and anti-filarial antibodies. Trans R Soc Trop Med Hyg 100: 656-662.
38. Ismail MM, Jayakody RL, Weil GJ, Fernando D, deSilva MSG, et al. (2001) Long-term efficacy of single-dose combinations of albendazole, ivermectin, and diethylcarbamazine for the treatment of lymphatic filariasis. Trans Roy Soc Trop Med Hyg 95: 332-335.